MarkRobertHancockMD

Oncology • Bozeman, MT

Genitourinary Oncology, Melanoma, Thoracic Cancer

Oncology Program Medical Director

Join to view full profile

Dr. Hancock is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hancock's full profile

Already have an account?

Office
931 Highland Blvd
Ste 3130
Bozeman, MT 59715
Phone+1 406-414-5070

Fax+1 406-414-5029

Education & Training

Daniels School of BusinessMBA, Business, 2007 - 2008
University of Texas Southwestern Medical CenterFellowship, Hematology and Medical Oncology, 1993 - 1995
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1989 - 1991
Virginia Commonwealth University Health SystemInternship, Internal Medicine, 1987 - 1988
University of Texas Southwestern Medical SchoolClass of 1987

Certifications & Licensure

MO State Medical License 2018 - 2026
TX State Medical License 1989 - 2026
CO State Medical License 2018 - 2025
MT State Medical License 2021 - 2025
SD State Medical License Active through 2023
KS State Medical License 2018 - 2022
American Board of Internal Medicine Medical Oncology

Clinical Trials

Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC
No longer available
A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer Start of enrollment: 2015 Jul 13
Completed
Phase 3

Publications & Presentations

PubMed

95 citations
Natural History and Factors Associated with Overall Survival in Stage IV ALK-Rearranged Non-Small Cell Lung Cancer.
Jose M. Pacheco, Dexiang Gao, Derek E. Smith, Thomas Purcell, Mark Hancock
Journal of Thoracic Oncology. 2019-04-01
128 citations
The Incidence of Brain Metastases in Stage IV ROS1-Rearranged Non-Small Cell Lung Cancer and Rate of Central Nervous System Progression on Crizotinib.
Tejas Patil, Derek E. Smith, Paul A. Bunn, Dara L. Aisner, Anh T. Le
Journal of Thoracic Oncology. 2018-11-01

Press Mentions

New hematologist/oncologist Joins Staff at HaysMedApril 16th, 2019

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Industry Relationships

Speaker, Guardent2016 - 2017